Variant report
Variant | nsv292826 |
---|---|
Chromosome Location | chr4:48320595-48328404 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:48322582..48325559-chr4:48331467..48333922,2 | K562 | blood: | |
2 | chr4:48322582..48327982-chr4:48329571..48333922,4 | K562 | blood: | |
3 | chr4:48321470..48323955-chr4:48341055..48342680,2 | K562 | blood: | |
4 | chr4:48270033..48272126-chr4:48328140..48330927,2 | K562 | blood: | |
5 | chr4:48317545..48320000-chr4:48323485..48325753,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000135605 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542506252 | chr4:48321210-48321211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs138720673 | chr4:48321225-48321226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs576831253 | chr4:48321329-48321330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187843002 | chr4:48321364-48321365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs543447774 | chr4:48321401-48321402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114233644 | chr4:48321409-48321410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs367863952 | chr4:48321410-48321411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574031935 | chr4:48321415-48321416 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs541234647 | chr4:48321449-48321450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559256856 | chr4:48321477-48321478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562622061 | chr4:48321492-48321493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551223779 | chr4:48321513-48321514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563233515 | chr4:48321542-48321543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs309876 | chr4:48321564-48321565 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs147343263 | chr4:48321586-48321587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs139789393 | chr4:48321597-48321598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542515625 | chr4:48323022-48323023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535585191 | chr4:48323056-48323057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs184832798 | chr4:48323083-48323084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs36022046 | chr4:48323262-48323263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs146585065 | chr4:48323268-48323269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528120839 | chr4:48323300-48323301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs112049779 | chr4:48323321-48323322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540210226 | chr4:48323351-48323352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11946788 | chr4:48323357-48323358 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs114670390 | chr4:48323385-48323386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs572368425 | chr4:48323413-48323414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534081227 | chr4:48323431-48323432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs373306706 | chr4:48323473-48323474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552023397 | chr4:48323483-48323484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528725632 | chr4:48324427-48324428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546611186 | chr4:48324442-48324443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs540395134 | chr4:48324453-48324454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140720468 | chr4:48324456-48324457 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs550708039 | chr4:48324470-48324471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs150472203 | chr4:48324529-48324530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs536089914 | chr4:48324538-48324539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs560071823 | chr4:48324549-48324550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs527323223 | chr4:48324581-48324582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145402662 | chr4:48324592-48324593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs372255233 | chr4:48324594-48324595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573073693 | chr4:48324621-48324622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149204603 | chr4:48324622-48324623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558597620 | chr4:48324625-48324626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181412976 | chr4:48324715-48324716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143330629 | chr4:48324734-48324735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs186505292 | chr4:48324766-48324767 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574458692 | chr4:48324769-48324770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs309882 | chr4:48324826-48324827 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs190477158 | chr4:48324917-48324918 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 22522925 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:48321200-48321600 | Enhancers | Liver | Liver |
2 | chr4:48323000-48323400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr4:48323000-48323600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr4:48324400-48324800 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
5 | chr4:48324400-48325200 | Enhancers | Placenta | Placenta |
6 | chr4:48324400-48326800 | Enhancers | K562 | blood |
7 | chr4:48324800-48325200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr4:48324800-48325200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr4:48324800-48325200 | Enhancers | Right Atrium | heart |
10 | chr4:48324800-48325600 | Enhancers | HUVEC | blood vessel |
11 | chr4:48324800-48331000 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
12 | chr4:48325200-48334200 | Weak transcription | Placenta | Placenta |
13 | chr4:48326800-48331200 | Weak transcription | K562 | blood |
14 | chr4:48327600-48331200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr4:48328200-48329800 | Weak transcription | HSMMtube | muscle |